Literature DB >> 34022876

Characterization and selection of Japanese electronic health record databases used as data sources for non-interventional observational studies.

Yumi Wakabayashi1, Masamitsu Eitoku2, Narufumi Suganuma2.   

Abstract

BACKGROUND: Interventional studies are the fundamental method for obtaining answers to clinical questions. However, these studies are sometimes difficult to conduct because of insufficient financial or human resources or the rarity of the disease in question. One means of addressing these issues is to conduct a non-interventional observational study using electronic health record (EHR) databases as the data source, although how best to evaluate the suitability of an EHR database when planning a study remains to be clarified. The aim of the present study is to identify and characterize the data sources that have been used for conducting non-interventional observational studies in Japan and propose a flow diagram to help researchers determine the most appropriate EHR database for their study goals.
METHODS: We compiled a list of published articles reporting observational studies conducted in Japan by searching PubMed for relevant articles published in the last 3 years and by searching database providers' publication lists related to studies using their databases. For each article, we reviewed the abstract and/or full text to obtain information about data source, target disease or therapeutic area, number of patients, and study design (prospective or retrospective). We then characterized the identified EHR databases.
RESULTS: In Japan, non-interventional observational studies have been mostly conducted using data stored locally at individual medical institutions (663/1511) or collected from several collaborating medical institutions (315/1511). Whereas the studies conducted with large-scale integrated databases (330/1511) were mostly retrospective (73.6%), 27.5% of the single-center studies, 47.6% of the multi-center studies, and 73.7% of the post-marketing surveillance studies, identified in the present study, were conducted prospectively. We used our findings to develop an assessment flow diagram to assist researchers in evaluating and choosing the most suitable EHR database for their study goals.
CONCLUSIONS: Our analysis revealed that the non-interventional observational studies were conducted using data stored local at individual medical institutions or collected from collaborating medical institutions in Japan. Disease registries, disease databases, and large-scale databases would enable researchers to conduct studies with large sample sizes to provide robust data from which strong inferences could be drawn.

Entities:  

Keywords:  Database; Medical information; Observational study; Prospective study; Real world; Retrospective study; Virtual trial

Year:  2021        PMID: 34022876     DOI: 10.1186/s12911-021-01526-6

Source DB:  PubMed          Journal:  BMC Med Inform Decis Mak        ISSN: 1472-6947            Impact factor:   2.796


  22 in total

1.  Usefulness of a healthcare database for epidemiological research in atrial fibrillation.

Authors:  Yukihiro Koretsune; Takeshi Yamashita; Masahiro Yasaka; Eisei Oda; Daisuke Matsubayashi; Kaori Ota; Masafumi Kobayashi; Yasuyuki Matsushita; Jumpei Kaburagi; Kei Ibusuki; Atsushi Takita; Mikio Iwashita; Takuhiro Yamaguchi
Journal:  J Cardiol       Date:  2016-12-24       Impact factor: 3.159

2.  Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade.

Authors:  Clifford R Jack; David S Knopman; William J Jagust; Leslie M Shaw; Paul S Aisen; Michael W Weiner; Ronald C Petersen; John Q Trojanowski
Journal:  Lancet Neurol       Date:  2010-01       Impact factor: 44.182

3.  Pre-Hospital Administration of Epinephrine in Pediatric Patients With Out-of-Hospital Cardiac Arrest.

Authors:  Tasuku Matsuyama; Sho Komukai; Junichi Izawa; Koichiro Gibo; Masashi Okubo; Kosuke Kiyohara; Takeyuki Kiguchi; Taku Iwami; Bon Ohta; Tetsuhisa Kitamura
Journal:  J Am Coll Cardiol       Date:  2020-01-21       Impact factor: 24.094

4.  Clinical and biomarker changes in dominantly inherited Alzheimer's disease.

Authors:  Randall J Bateman; Chengjie Xiong; Tammie L S Benzinger; Anne M Fagan; Alison Goate; Nick C Fox; Daniel S Marcus; Nigel J Cairns; Xianyun Xie; Tyler M Blazey; David M Holtzman; Anna Santacruz; Virginia Buckles; Angela Oliver; Krista Moulder; Paul S Aisen; Bernardino Ghetti; William E Klunk; Eric McDade; Ralph N Martins; Colin L Masters; Richard Mayeux; John M Ringman; Martin N Rossor; Peter R Schofield; Reisa A Sperling; Stephen Salloway; John C Morris
Journal:  N Engl J Med       Date:  2012-07-11       Impact factor: 91.245

5.  Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.

Authors:  Stephen Salloway; Reisa Sperling; Nick C Fox; Kaj Blennow; William Klunk; Murray Raskind; Marwan Sabbagh; Lawrence S Honig; Anton P Porsteinsson; Steven Ferris; Marcel Reichert; Nzeera Ketter; Bijan Nejadnik; Volkmar Guenzler; Maja Miloslavsky; Daniel Wang; Yuan Lu; Julia Lull; Iulia Cristina Tudor; Enchi Liu; Michael Grundman; Eric Yuen; Ronald Black; H Robert Brashear
Journal:  N Engl J Med       Date:  2014-01-23       Impact factor: 91.245

6.  Citizen bystander-patient relationship and 1-month outcomes after out-of-hospital cardiac arrest of cardiac origin from the All-Japan Utstein Registry: a prospective, nationwide, population-based, observational study.

Authors:  Yasunori Suematsu; Bo Zhang; Keijiro Saku; Shin-Ichiro Miura; Takashi Kuwano; Hideto Sako; Masahiro Ogawa; Naohiro Yonemoto; Hiroshi Nonogi; Takeshi Kimura; Ken Nagao; Shin'ichiro Yasunaga
Journal:  BMJ Open       Date:  2019-07-26       Impact factor: 2.692

7.  Treatment patterns, persistence and adherence rates in patients with type 2 diabetes mellitus in Japan: a claims-based cohort study.

Authors:  Rimei Nishimura; Haruka Kato; Koichi Kisanuki; Akinori Oh; Shinzo Hiroi; Yoshie Onishi; Florent Guelfucci; Yukio Shimasaki
Journal:  BMJ Open       Date:  2019-03-01       Impact factor: 2.692

8.  Influenza vaccination effectiveness for people aged under 65 years in Japan, 2013/2014 season: application of a doubly robust method to a large-scale, real-world dataset.

Authors:  Natsumi Shibata; Shinya Kimura; Takahiro Hoshino; Hisashi Urushihara
Journal:  BMC Infect Dis       Date:  2019-07-05       Impact factor: 3.090

9.  Healthcare Databases in Thailand and Japan: Potential Sources for Health Technology Assessment Research.

Authors:  Surasak Saokaew; Takashi Sugimoto; Isao Kamae; Chayanin Pratoomsoot; Nathorn Chaiyakunapruk
Journal:  PLoS One       Date:  2015-11-11       Impact factor: 3.240

10.  Advancing a Framework for Regulatory Use of Real-World Evidence: When Real Is Reliable.

Authors:  Nancy A Dreyer
Journal:  Ther Innov Regul Sci       Date:  2018-03-19       Impact factor: 1.778

View more
  1 in total

Review 1.  Context and Considerations for Use of Two Japanese Real-World Databases in Japan: Medical Data Vision and Japanese Medical Data Center.

Authors:  Thomas Laurent; Jason Simeone; Ryohei Kuwatsuru; Takahiro Hirano; Sophie Graham; Ryozo Wakabayashi; Robert Phillips; Tatsuya Isomura
Journal:  Drugs Real World Outcomes       Date:  2022-03-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.